Advertisement Watson, Arrow Group Receive FTC Second Request - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Watson, Arrow Group Receive FTC Second Request

In connection with Watson's pending acquisition of Arrow Group

Watson has received a request for additional information from the Federal Trade Commission (FTC) in connection with Watson’s pending acquisition of Arrow Group.

The information request was issued under notification requirements of the Hart.Scott.Rodino Antitrust Improvements Act of 1976, as amended (HSR Act).

The effect of the second request is to extend the waiting period imposed by the HSR Act until 30 days after Watson and Arrow Group have substantially complied with the request, unless that period is extended voluntarily by the parties or terminated sooner by the FTC.

Watson will cooperate with the FTC’s review and expects the transaction to close in the second half of 2009.